$10.03 0.0 0.4%
Last Trade - 16/04/21
| Market Cap | £7.25 |
| Enterprise Value | £n/a |
| Revenue | £n/a |
| Position in Universe | 6828th / 6850 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 01st Jan | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Panacea Acquisition Corp. II is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target and has not, nor has anyone on behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The Company intend to identify companies in the biotechnology sector that are domiciled in North America or Europe. The Company has not commenced any operations nor generated any revenues.
| Last Annual | January 1st, 1970 |
| Last Interim | January 1st, 1970 |
| Incorporated | January 14, 2021 |
| Public Since | April 7, 2021 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Financials |
| Industry | Holding Companies |
| Index | |
| Exchange | NASDAQ Capital Market |
| Shares in Issue | |
| Free Float | (0.0%) |
| Eligible for |
×
ISAs
✓
SIPPs
|
As of 16/04/21, shares in Panacea Acquisition II are trading at $10.03, giving the company a market capitalisation of £7.25. This share price information is delayed by 15 minutes.
Shares in Panacea Acquisition II are currently trading at $10.03 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Panacea Acquisition II price has moved by % over the past year.
There are no analysts currently covering Panacea Acquisition II.
It is not known when Panacea Acquisition II will next release financial results.
Panacea Acquisition II does not currently pay a dividend.
Panacea Acquisition II does not currently pay a dividend.
Panacea Acquisition II does not currently pay a dividend.
To buy shares in Panacea Acquisition II you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Panacea Acquisition II are currently trading at $10.03, giving the company a market capitalisation of £7.25.
Here are the trading details for Panacea Acquisition II:
We were not able to load our ranking data for Panacea Acquisition II
We were not able to load any forecast data for Panacea Acquisition II.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Panacea Acquisition II. Over the past six months, the relative strength of its shares against the market has been %. At the current price of $10.03, shares in Panacea Acquisition II are trading at 0.27% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Panacea Acquisition II.
We were unable to find the directors for Panacea Acquisition II.
Here are the top five shareholders of Panacea Acquisition II based on the size of their shareholding:
